Diversicare Completes $100 Million Refinancing and Exercises Purchase Options
Feb 29, 2016 13:00 pm UTC| Business
BRENTWOOD, Tenn., Feb. 29, 2016 -- Diversicare Healthcare Services, Inc. (NASDAQ:DVCR), a premier provider of long-term care services, today announced that effective February 26, 2016 the Company has exercisedits real...
Immune Design to Present at Cowen and Company 36th Annual Health Care Conference
Feb 29, 2016 13:00 pm UTC| Business
SEATTLE and SOUTH SAN FRANCISCO, Calif., Feb. 29, 2016 -- Immune Design (Nasdaq:IMDZ), a clinical-stage immunotherapy company focused on oncology, today announced that Carlos Paya, M.D., Ph.D., President and Chief...
Feb 29, 2016 13:00 pm UTC| Business
--Study to Evaluate ONT-380 in Combination with Herceptin and Xeloda-- --Study Will Enroll HER2-Positive Breast Cancer Patients With and Without Brain Metastases-- SEATTLE, Feb. 29, 2016 -- Oncothyreon Inc....
Icahn Enterprises L.P. Reports Fourth Quarter and Full Year 2015 Financial Results
Feb 29, 2016 13:00 pm UTC| Business
NEW YORK, Feb. 29, 2016 -- Icahn Enterprises L.P. (NASDAQ:IEP) is reporting full year 2015 revenues of $15.3 billion and adjusted net loss attributable to Icahn Enterprises, after adding back the loss on extinguishment...
Genocea to Present at the Cowen and Company 36th Annual Health Care Conference
Feb 29, 2016 13:00 pm UTC| Business
CAMBRIDGE, Mass., Feb. 29, 2016 -- Genocea Biosciences, Inc.(NASDAQ:GNCA), a biopharmaceutical company developing T cell-directed vaccines and immunotherapies, today announced that Chip Clark, president and chief...
NXP Semiconductors to Host Investor Day
Feb 29, 2016 13:00 pm UTC| Business
EINDHOVEN, the Netherlands, Feb. 29, 2016 -- NXP Semiconductors N.V. (NASDAQ:NXPI) announced today it will host an Investor Day for buy-side institutional investors and sell-side equity analysts on April 28, 2016. The...
Intra-Cellular Therapies to Present at the Cowen and Company 36th Annual Health Care Conference
Feb 29, 2016 13:00 pm UTC| Business
NEW YORK, Feb. 29, 2016 -- Intra-Cellular Therapies, Inc. (Nasdaq:ITCI), a biopharmaceutical company focused on the development of therapeutics for central nervous system ("CNS") disorders, today announced that Sharon...